Childhood pemphigus vulgaris successfully treated with rituximab.
Indian J Dermatol Venereol Leprol
;
2012 Sept-Oct; 78(5): 632-634
Article
in English
| IMSEAR
| ID: sea-141179
ABSTRACT
Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an 11-year-old boy of childhood pemphigus vulgaris who failed to respond to dexamethasone pulse therapy and was subsequently treated with rituximab and achieved complete remission.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Language:
English
Journal:
Indian J Dermatol Venereol Leprol
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS